NicOx

NicOx S.A.
Stock Exchange Other OTC
EPS
$0.73
Market Cap
$163.91 M
Shares Outstanding
29.59 M
Public Float
-
NicOx S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
29.59 M
Public Float
-
NicOx S.A.
Stock Exchange Euronext Paris
EPS
EUR0.62
Market Cap
EUR145.81 M
Shares Outstanding
29.91 M
Public Float
26.84 M

Profile

Address
Drakkar 2 - Bât D
Sophia-Antipolis Provence-Alpes-Cote-dAzur 06560
France
Employees -
Website http://www.nicox.com
Updated 07/08/2019
Nicox SA is an ophthalmology company, which engages in developing innovative solutions to help maintain vision and improve ocular health. Its products include Zerviate, and Vyzulta. The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.

Financials

View All

Michele Garufi
Chairman & Chief Executive Officer
Lauren P. Silvernail
Independent Director